177 related articles for article (PubMed ID: 12761630)
1. Functional imaging in Parkinson's disease: activation studies with PET, fMRI and SPECT.
Ceballos-Baumann AO
J Neurol; 2003 Feb; 250 Suppl 1():I15-23. PubMed ID: 12761630
[TBL] [Abstract][Full Text] [Related]
2. [SPECT and PET in Parkinson's disease].
Matsuda H
Nihon Rinsho; 2000 Oct; 58(10):2000-6. PubMed ID: 11068438
[TBL] [Abstract][Full Text] [Related]
3. Task specific influences of Parkinson's disease on the striato-thalamo-cortical and cerebello-thalamo-cortical motor circuitries.
Lewis MM; Slagle CG; Smith AB; Truong Y; Bai P; McKeown MJ; Mailman RB; Belger A; Huang X
Neuroscience; 2007 Jun; 147(1):224-35. PubMed ID: 17499933
[TBL] [Abstract][Full Text] [Related]
4. Subthalamic nucleus stimulation and dysarthria in Parkinson's disease: a PET study.
Pinto S; Thobois S; Costes N; Le Bars D; Benabid AL; Broussolle E; Pollak P; Gentil M
Brain; 2004 Mar; 127(Pt 3):602-15. PubMed ID: 14736753
[TBL] [Abstract][Full Text] [Related]
5. [PET and SPECT in Parkinson's disease].
Blesa R
Rev Neurol; 1997 Aug; 25 Suppl 2():S147-50. PubMed ID: 9280681
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of Parkinson's disease and related syndromes using 123I-IMP-SPECT with the ARG method].
Kageyama H; Kikuchi S; Tashiro K
Nihon Rinsho; 1997 Jan; 55(1):238-42. PubMed ID: 9014457
[TBL] [Abstract][Full Text] [Related]
7. SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease.
Imon Y; Matsuda H; Ogawa M; Kogure D; Sunohara N
J Nucl Med; 1999 Oct; 40(10):1583-9. PubMed ID: 10520695
[TBL] [Abstract][Full Text] [Related]
8. Brain networks underlying the clinical effects of long-term subthalamic stimulation for Parkinson's disease: a 4-year follow-up study with rCBF SPECT.
Sestini S; Ramat S; Formiconi AR; Ammannati F; Sorbi S; Pupi A
J Nucl Med; 2005 Sep; 46(9):1444-54. PubMed ID: 16157526
[TBL] [Abstract][Full Text] [Related]
9. Cerebral activity modulation by extradural motor cortex stimulation in Parkinson's disease: a perfusion SPECT study.
Cilia R; Marotta G; Landi A; Isaias IU; Vergani F; Benti R; Sganzerla E; Gerundini P; Pezzoli G; Antonini A
Eur J Neurol; 2008 Jan; 15(1):22-8. PubMed ID: 18042244
[TBL] [Abstract][Full Text] [Related]
10. Functional imaging in Parkinson's disease.
Dagher A
Semin Neurol; 2001; 21(1):23-32. PubMed ID: 11346022
[TBL] [Abstract][Full Text] [Related]
11. Changes in regional cerebral blood flow caused by deep-brain stimulation of the subthalamic nucleus in Parkinson's disease.
Sestini S; Scotto di Luzio A; Ammannati F; De Cristofaro MT; Passeri A; Martini S; Pupi A
J Nucl Med; 2002 Jun; 43(6):725-32. PubMed ID: 12050315
[TBL] [Abstract][Full Text] [Related]
12. Quantitative comparison of functional magnetic resonance imaging with positron emission tomography using a force-related paradigm.
Dettmers C; Connelly A; Stephan KM; Turner R; Friston KJ; Frackowiak RS; Gadian DG
Neuroimage; 1996 Dec; 4(3 Pt 1):201-9. PubMed ID: 9345510
[TBL] [Abstract][Full Text] [Related]
13. PET and SPECT studies in Parkinson's disease.
Brooks DJ
Baillieres Clin Neurol; 1997 Apr; 6(1):69-87. PubMed ID: 9426869
[TBL] [Abstract][Full Text] [Related]
14. Use of functional imaging in Parkinsonism and dementia.
Burn DJ; O'Brien JT
Mov Disord; 2003 Sep; 18 Suppl 6():S88-95. PubMed ID: 14502661
[TBL] [Abstract][Full Text] [Related]
15. CBF changes during brain activation: fMRI vs. PET.
Feng CM; Narayana S; Lancaster JL; Jerabek PA; Arnow TL; Zhu F; Tan LH; Fox PT; Gao JH
Neuroimage; 2004 May; 22(1):443-6. PubMed ID: 15110037
[TBL] [Abstract][Full Text] [Related]
16. The use of PET in Parkinson's disease.
Shinotoh H; Calne DB
Brain Cogn; 1995 Aug; 28(3):297-310. PubMed ID: 8546856
[TBL] [Abstract][Full Text] [Related]
17. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
Pirker W
Mov Disord; 2003 Oct; 18 Suppl 7():S43-51. PubMed ID: 14531046
[TBL] [Abstract][Full Text] [Related]
18. Functional brain imaging of movement disorders.
Eidelberg D; Edwards C
Neurol Res; 2000 Apr; 22(3):305-12. PubMed ID: 10769825
[TBL] [Abstract][Full Text] [Related]
19. Functional mapping of human sensorimotor cortex with 3D BOLD fMRI correlates highly with H2(15)O PET rCBF.
Ramsey NF; Kirkby BS; Van Gelderen P; Berman KF; Duyn JH; Frank JA; Mattay VS; Van Horn JD; Esposito G; Moonen CT; Weinberger DR
J Cereb Blood Flow Metab; 1996 Sep; 16(5):755-64. PubMed ID: 8784221
[TBL] [Abstract][Full Text] [Related]
20. Significance of non-presynaptic SPECT tracer methods in Parkinson's disease.
Leenders KL
Mov Disord; 2003 Oct; 18 Suppl 7():S39-42. PubMed ID: 14531045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
